Alias
科研级 Nimotuzumab ( 尼妥组单抗 ), Anti-EGFR Recombinant Antibody, Research Grade Nimotuzumab
Molecular Name
Nimotuzumab
Applications
ELISA, IP, FC, FuncS, Neut, IF, IHC
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
EGFR[Homo sapiens]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Nimotuzumab (h-R3, BIOMAb EGFR, Biocon, India, TheraCIM, CIMYM Biosciences, Canada, Theraloc, Oncoscience, Europe, CIMAher, Center of Molecular Immunology, Havana, Cuba) is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck, and was undergoing several clinical trials.
Storage
该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。